相关实验视频
Updated: Jan 17, 2026

09:22
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
18.9K
在阿尔茨海默病中,SUMO 抑制了 Tau 聚合
Subashchandrabose Chinnathambi1, Nagaraj Rangappa1
1Department of Neurochemistry, National Institute of Mental Health and Neuro Sciences Hospital (NIMHANS), Institute of National Importance, Bangalore, Karnataka, India.
Advances in protein chemistry and structural biology
|September 19, 2025
概括
在K340的Tau蛋白的SUMOylation刺激其酸化并抑制降解,促进聚合. 这种翻译后的修改影响了微管结合和神经元稳定性.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 陶蛋白对于神经元中的微管稳定性至关重要.
- 异常的陶酸化导致神经纤维状结和神经元功能障碍.
- 经历了各种翻译后的修改,包括SUMOylation和ubiquitination.
研究的目的:
- 调查SUMOylation在K340在Tau酸化和降解中的作用.
- 了解SUMOylation如何影响Tau聚合.
主要方法:
- 在Tau上确定SUMOylation站点.
- 评估SUMOylation对Tau酸化的影响.
- 评估SUMOylation对Tau泛化和降解途径的影响.
主要成果:
- 在lysine K340中确定了Tau的SUMOylation.
- 在K340的SUMOylation被证明可以刺激陶酸化.
- SUMOylation 抑制了无处不在化介导的 Tau 降解,有利于聚合.
结论:
- 在K340的SUMOylation是Tau病理学的关键调节者.
- 向TAU SUMOylation可能为神经退行性疾病提供治疗策略.
相关概念视频
Alzheimer's Disease: Treatment
825
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
825
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K

